Bifidobacteria (Bifidobacterium Longum) + Bifidobacterium bifidum + Fructo Oligosaccharide (FOS) + Lactobacillus acidophilus + Lactobacillus rhamnosus + Saccharomyces boulardii + Streptococcus thermophilus] is a multi-strain synbiotic formulation combining six probiotic microorganisms with fructo-oligosaccharide (FOS), a prebiotic that selectively nourishes beneficial gut bacteria. The probiotic strains include two Bifidobacterium species, two Lactobacillus species, Saccharomyces boulardii, and Streptococcus thermophilus, collectively providing broad-spectrum restoration and maintenance of gut microbiome balance. FOS supports the growth and activity of these beneficial organisms, enhancing the overall synbiotic effect. This combination is used in the management of dysbiosis, antibiotic-associated diarrhoea, irritable bowel syndrome, and immune support. Always use Bifidobacteria (Bifidobacterium Longum) + Bifidobacterium bifidum + Fructo Oligosaccharide (FOS) + Lactobacillus acidophilus + Lactobacillus rhamnosus + Saccharomyces boulardii + Streptococcus thermophilus] exactly as directed by your doctor.
Bifidobacteria (Bifidobacterium Longum) + Bifidobacterium bifidum + Fructo Oligosaccharide (FOS) + Lactobacillus acidophilus + Lactobacillus rhamnosus + Saccharomyces boulardii + Streptococcus thermophilus] is a synbiotic formulation combining the distinct and complementary properties of six probiotic strains with the prebiotic substrate fructo-oligosaccharide.
Bifidobacterium longum is one of the most prevalent and clinically studied gut commensals. It produces short-chain fatty acids that acidify the colonic environment, inhibiting pathogenic organisms, reducing intestinal permeability, and modulating immune responses. It also reduces pro-inflammatory cytokine production and is particularly beneficial in irritable bowel syndrome and antibiotic-associated dysbiosis.
Bifidobacterium bifidum colonises the large intestine and mucous membranes of the gut, where it supports barrier integrity and competes with pathogens for adhesion sites. It produces lactic and acetic acid, reducing luminal pH and inhibiting pathogen growth.
Lactobacillus acidophilus is a well-established probiotic with strong adhesion to intestinal epithelial cells. It produces bacteriocins and lactic acid that inhibit enteric pathogens, supports lactase activity reducing lactose intolerance symptoms, and modulates immune responses by stimulating regulatory T cells.
Lactobacillus rhamnosus is one of the most extensively studied probiotic strains. It is particularly effective in preventing and reducing the duration of antibiotic-associated and infectious diarrhoea, strengthening tight junction proteins of the gut barrier, and modulating mucosal immune responses.
Saccharomyces boulardii is a non-pathogenic yeast probiotic resistant to antibiotics, allowing it to remain effective during antibiotic therapy. It inhibits pathogen toxin binding, reduces intestinal secretion, and stimulates secretory IgA production at mucosal surfaces.
Streptococcus thermophilus produces lactase and lactic acid, supporting lactose digestion, reducing gut inflammation, and contributing to a favourable gut environment for other probiotic strains.
Fructo-oligosaccharide is a non-digestible prebiotic fibre that selectively stimulates the growth and metabolic activity of Bifidobacterium and Lactobacillus species. By providing a specific fermentable substrate, FOS enhances the colonisation, survival, and efficacy of the probiotic components.
The uses of Bifidobacteria (Bifidobacterium Longum) + Bifidobacterium bifidum + Fructo Oligosaccharide (FOS) + Lactobacillus acidophilus + Lactobacillus rhamnosus + Saccharomyces boulardii + Streptococcus thermophilus] are as follows:
Bifidobacteria (Bifidobacterium Longum) + Bifidobacterium bifidum + Fructo Oligosaccharide (FOS) + Lactobacillus acidophilus + Lactobacillus rhamnosus + Saccharomyces boulardii + Streptococcus thermophilus] is used to prevent and manage diarrhoea resulting from antibiotic-induced disruption of gut microbiome balance.
It is used to reduce symptoms of bloating, altered bowel habits, and abdominal discomfort associated with IBS.
Saccharomyces boulardii and Lactobacillus rhamnosus are particularly effective in reducing the duration and severity of acute infectious diarrhoea.
It is used to replenish and diversify the gut microbiome following dysbiosis caused by illness, antibiotics, or dietary disruption.
Lactobacillus acidophilus and Streptococcus thermophilus support lactase activity, reducing symptoms of lactose intolerance.
The combined immunomodulatory activity of the probiotic strains supports mucosal and systemic immune function.
Here are the benefits of Bifidobacteria (Bifidobacterium Longum) + Bifidobacterium bifidum + Fructo Oligosaccharide (FOS) + Lactobacillus acidophilus + Lactobacillus rhamnosus + Saccharomyces boulardii + Streptococcus thermophilus]:
Like all medicines, Bifidobacteria (Bifidobacterium Longum) + Bifidobacterium bifidum + Fructo Oligosaccharide (FOS) + Lactobacillus acidophilus + Lactobacillus rhamnosus + Saccharomyces boulardii + Streptococcus thermophilus] may cause side effects in some individuals.
Always consult your doctor if side effects persist or worsen.
To ensure safe use:
Bifidobacteria (Bifidobacterium Longum) + Bifidobacterium bifidum + Fructo Oligosaccharide (FOS) + Lactobacillus acidophilus + Lactobacillus rhamnosus + Saccharomyces boulardii + Streptococcus thermophilus] works through multiple complementary mechanisms that collectively restore and maintain gut microbiome balance and mucosal immune function.
Lactobacillus and Bifidobacterium species produce lactic and acetic acids, lowering colonic pH and inhibiting the growth of pathogenic organisms through competitive exclusion. They also produce bacteriocins, antimicrobial peptides that directly inhibit enteric pathogens, and reinforce tight junction proteins between intestinal epithelial cells, reducing barrier permeability.
Lactobacillus rhamnosus and Bifidobacterium longum modulate mucosal immune responses by stimulating secretory IgA production, enhancing regulatory T cell activity, and reducing pro-inflammatory cytokine production, supporting a balanced and non-excessive immune response at mucosal surfaces.
Saccharomyces boulardii inhibits pathogen toxin binding to intestinal receptors and reduces pathogen-induced secretory diarrhoea. Its resistance to antibiotics ensures continued probiotic activity during antibiotic treatment when bacterial strains may be suppressed.
FOS passes undigested to the colon where it is selectively fermented by Bifidobacterium and Lactobacillus species, stimulating their growth and short-chain fatty acid production. Short-chain fatty acids including butyrate provide energy for colonocytes, reduce colonic pH, and exert anti-inflammatory effects on the intestinal mucosa.
Inform your doctor of any known allergy to yeast, dairy-derived organisms, or FOS before use. Saccharomyces boulardii is yeast-derived.
Probiotic and prebiotic supplementation is generally considered safe during breastfeeding. Consult your doctor for guidance.
Probiotic formulations are generally considered safe during pregnancy at recommended doses. Use as directed by your doctor.
No significant impairment expected under normal use.
Excessive alcohol disrupts gut microbiome balance and may reduce the therapeutic benefit of probiotic supplementation.
Use carefully in significant hepatic impairment. Saccharomyces boulardii has rarely been associated with fungaemia in patients with severe liver disease. Consult your doctor.
No significant renal concerns expected at recommended doses.
Probiotic formulations are widely used in children. Age-appropriate formulations and doses should be confirmed by a doctor.
Generally well tolerated in elderly patients. Probiotic supplementation may particularly benefit elderly individuals with age-related microbiome decline.
A few practical measures can help improve treatment outcomes and ensure safe use of Bifidobacteria (Bifidobacterium Longum) + Bifidobacterium bifidum + Fructo Oligosaccharide (FOS) + Lactobacillus acidophilus + Lactobacillus rhamnosus + Saccharomyces boulardii + Streptococcus thermophilus]:
Proper storage is important to maintain the stability and viability of Bifidobacteria (Bifidobacterium Longum) + Bifidobacterium bifidum + Fructo Oligosaccharide (FOS) + Lactobacillus acidophilus + Lactobacillus rhamnosus + Saccharomyces boulardii + Streptococcus thermophilus]:
Bifidobacteria (Bifidobacterium Longum) + Bifidobacterium bifidum + Fructo Oligosaccharide (FOS) + Lactobacillus acidophilus + Lactobacillus rhamnosus + Saccharomyces boulardii + Streptococcus thermophilus] may generally be taken without strict dietary restrictions. However:
Bifidobacteria (Bifidobacterium Longum) + Bifidobacterium bifidum + Fructo Oligosaccharide (FOS) + Lactobacillus acidophilus + Lactobacillus rhamnosus + Saccharomyces boulardii + Streptococcus thermophilus] may interact with the following medicines:
Bifidobacteria (Bifidobacterium Longum) + Bifidobacterium bifidum + Fructo Oligosaccharide (FOS) + Lactobacillus acidophilus + Lactobacillus rhamnosus + Saccharomyces boulardii + Streptococcus thermophilus] should be used carefully in the following conditions:
Usually taken once or twice daily with food as directed by your doctor. Dose and duration depend on the clinical indication and specific formulation.
If a dose is missed, take it as soon as remembered. Do not double the dose to make up for a missed one.
Therapeutic Class
Gastroenterology / Nutraceutical
Action Class
Probiotic + Prebiotic / Gut Microbiome Modulator
Chemical Class
Multi-Strain Probiotic + Prebiotic Fibre (Synbiotic)
Habit Forming
No
Checkout Editorial Policy